Testing low-dose radiation with immunotherapy for oral cancer
Part of Cancer clinical trials.
This trial tests a combination of low-dose radiation, immunotherapy, and chemotherapy for people with advanced oral squamous cell carcinoma (a type of mouth cancer) who have not had any prior cancer treatment. The goal is to see if this approach can shrink tumors safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have stage III, IVA, or IVB oral squamous cell carcinoma that has not spread to other parts of the body.
- You must not have received any previous cancer treatment (surgery, radiation, chemo, immunotherapy, etc.).
- You must be in generally good health, with normal blood counts and organ function (heart, liver, kidneys).
- You must be willing to use effective birth control during and for 8 weeks after treatment, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding targeted radiation (SBRT) to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for people with advanced mouth or throat cancer. It aims to shrink the tumor more effectively before removal.
This trial tests a combination of three drugs (adebrelimab, carboplatin, and albumin-bound paclitaxel) before surgery for people with advanced mouth cancer that can be removed. The goal is to see if this treatment can help shrink the tumor and improve outcomes.
This trial tests whether adding an immunotherapy drug (sintilimab) to standard chemotherapy before and after surgery can improve outcomes for people with advanced oral squamous cell carcinoma. The treatment is given first to shrink the tumor, then again after surgery to help prevent recurrence.
This trial tests if combining a low dose of radiation with an immunotherapy drug (adebrelimab) and a chemotherapy drug (albumin-bound paclitaxel) before surgery can help treat early-stage oral squamous cell carcinoma. It aims to see if this combination is safe and effective.
This trial tests a combination of low-dose radiation and an immunotherapy drug (similar to Keytruda) given before surgery for advanced head and neck cancer. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests combining radiation therapy with immunotherapy and chemotherapy before surgery for advanced oral or throat cancer. The goal is to see if this approach can shrink the tumor and improve treatment outcomes.
Hear when a new Oral Squamous Cell Carcinoma (OSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.